Sun Pharma Q4 Results: Sun Pharmaceutical Industries reported a 19% YoY decline in Q4FY25 profit at ?2,153.93 crore. However, total revenue rose 8% YoY to ?12,958.84 crore, and EBITDA increased 22% to ?3,716 crore.
Sun Pharma Q4 Results: Sun Pharmaceutical Industries reported a 19% YoY decline in Q4FY25 profit at ?2,153.93 crore. However, total revenue rose 8% YoY to ?12,958.84 crore, and EBITDA increased 22% to ?3,716 crore.